Immunovant (IMVT) Insider Trading & Ownership $26.63 -1.42 (-5.06%) (As of 11/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Immunovant (NASDAQ:IMVT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$6.21 M Get IMVT Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunovant stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IMVT Insider Buying and Selling by Quarter Ad Porter & CompanyFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. Immunovant Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/23/2024Jay S StoutCTOSell2,740$29.53$80,912.20 10/23/2024Mark S LevineInsiderSell4,361$29.53$128,780.33 10/16/2024Eva Renee BarnettCFOSell3,271$28.79$94,172.09 10/16/2024Peter SalzmannCEOSell9,095$28.79$261,845.05 10/16/2024William L MaciasInsiderSell3,188$28.79$91,782.52 10/9/2024Eva Renee BarnettCFOSell5,162$29.56$152,588.72 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/9/2024Peter SalzmannCEOSell4,460$29.56$131,837.60 7/24/2024Jay S StoutCTOSell2,813$27.76$78,088.88 7/24/2024Michael GeffnerInsiderSell3,456$27.76$95,938.56 7/17/2024Eva Renee BarnettCFOSell3,123$29.69$92,721.87 7/17/2024Mark S LevineInsiderSell2,505$29.69$74,373.45 7/17/2024Peter SalzmannCEOSell8,685$29.69$257,857.65 7/9/2024Eva Renee BarnettCFOSell4,747$28.06$133,200.82 7/9/2024Julia G ButchkoInsiderSell1,527$28.06$42,847.62 7/9/2024Peter SalzmannCEOSell4,619$28.06$129,609.14 5/22/2024Eva Renee BarnettCFOSell4,042$29.65$119,845.30 5/22/2024Julia G ButchkoInsiderSell3,247$29.65$96,273.55 5/22/2024Peter SalzmannCEOSell16,163$29.65$479,232.95 4/24/2024Jay S StoutCTOSell7,239$28.90$209,207.10 4/24/2024Michael GeffnerInsiderSell3,261$28.90$94,242.90 4/17/2024Eva Renee BarnettCFOSell12,253$29.06$356,072.18 4/17/2024Julia G ButchkoInsiderSell10,115$29.06$293,941.90 4/17/2024Peter SalzmannCEOSell34,079$29.06$990,335.74 4/9/2024Eva Renee BarnettCFOSell3,689$31.18$115,023.02 4/9/2024Julia G ButchkoInsiderSell1,053$31.18$32,832.54 4/9/2024Peter SalzmannCEOSell4,807$31.18$149,882.26 2/22/2024Eva Renee BarnettCFOSell2,930$36.15$105,919.50 2/22/2024Mark S LevineInsiderSell2,134$36.15$77,144.10 1/26/2024Mark S LevineInsiderSell3,027$37.92$114,783.84 1/18/2024William L MaciasInsiderSell424$41.03$17,396.72 1/11/2024Eva Renee BarnettCFOSell3,515$41.83$147,032.45 1/5/2024Julia G ButchkoInsiderSell1,297$38.59$50,051.23 1/5/2024Peter SalzmannCEOSell3,824$38.59$147,568.16 11/22/2023Eva Renee BarnettCFOSell4,055$32.78$132,922.90 11/22/2023Julia G ButchkoInsiderSell3,265$32.78$107,026.70 11/22/2023Peter SalzmannCEOSell16,217$32.78$531,593.26 (Data available from 1/1/2013 forward) IMVT Insider Trading Activity - Frequently Asked Questions Who is on Immunovant's Insider Roster? The list of insiders at Immunovant includes Eva Renee Barnett, Frank Torti, Jay S Stout, Julia G Butchko, Mark S Levine, Michael Geffner, Peter Salzmann, Sciences Ltd. Roivant, and William L Macias. Learn more on insiders at IMVT. What percentage of Immunovant stock is owned by insiders? 5.90% of Immunovant stock is owned by insiders. Learn more on IMVT's insider holdings. Which Immunovant insiders have been buying company stock? The following insider purchased IMVT shares in the last 24 months: Sciences Ltd. Roivant ($58,000,008.00). How much insider buying is happening at Immunovant? Insiders have purchased a total of 1,526,316 IMVT shares in the last 24 months for a total of $58,000,008.00 bought. Which Immunovant insiders have been selling company stock? The following insiders have sold IMVT shares in the last 24 months: Eva Renee Barnett ($2,105,552.30), Jay S Stout ($368,208.18), Julia G Butchko ($1,754,057.02), Mark S Levine ($1,059,548.41), Michael Geffner ($190,181.46), Peter Salzmann ($9,112,567.02), and William L Macias ($157,394.17). How much insider selling is happening at Immunovant? Insiders have sold a total of 608,755 Immunovant shares in the last 24 months for a total of $14,747,508.56 sold. Immunovant Key ExecutivesDr. Frank M. Torti M.B.A. (Age 45)M.D., Executive Chairperson of the Board Compensation: $92.5kDr. Peter Salzmann M.B.A. (Age 56)M.D., CEO & Director Compensation: $1.02MMs. Eva Renee Barnett M.B.A. (Age 43)Chief Financial Officer Compensation: $871.07k5 recent tradesDr. William L. Macias M.D. (Age 65)Ph.D., Chief Medical Officer Compensation: $719.88kDr. Jay S. Stout Ph.D. (Age 60)Chief Technology Officer Dr. Chau Cheng M.B.A.Ph.D., Vice President of Investor RelationsMr. Mark S. Levine (Age 51)Chief Legal Officer & Corporate Secretary 2 recent tradesMs. Lauren Schrier M.B.A.Vice President of MarketingMs. Christine BlodgettVice President of Human ResourcesDr. Julia G. Butchko Ph.D. (Age 53)Chief Development Officer Compensation: $531k More Insider Trading Tools from MarketBeat Related Companies UTZ Insider Trading ADV Insider Trading HYLN Insider Trading MPLN Insider Trading GMAB Insider Trading SMMT Insider Trading VTRS Insider Trading PCVX Insider Trading SRPT Insider Trading CTLT Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:IMVT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovant, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunovant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.